P3 Health Q3 2023 Earnings Report
Key Takeaways
P3 Health Partners reported a 16% increase in total revenue to $288.4 million for the third quarter of 2023, with a net loss of $37.3 million. The company reaffirmed its full-year 2023 guidance and provided preliminary 2024 full-year Adjusted EBITDA guidance of $20 million to $40 million.
Total revenue increased by 16% to $288.4 million compared to the third quarter of the prior year.
Net loss decreased by approximately 43% to $37.3 million compared to the third quarter of the prior year.
Adjusted EBITDA loss was $22.3 million, compared to an Adjusted EBITDA loss of $40.3 million in the third quarter of the prior year.
Gross profit was $9.1 million, compared to negative $6.5 million in the prior year.
P3 Health
P3 Health
Forward Guidance
The company reaffirmed its full-year 2023 guidance and provided preliminary 2024 full-year Adjusted EBITDA guidance of $20 million to $40 million.